Abstract: The present invention relates to a transmitter and a receiver for a mobile communication system. The basic idea of the present invention is to target the number of HARQ transmissions that is required to be able to decode the transmitted data successfully and to only transmit HARQ feedback information if the decoding result differs from an expected result, wherein the expected result is based on the targeted number of required HARQ transmissions.
Type:
Grant
Filed:
December 16, 2005
Date of Patent:
April 3, 2012
Assignee:
Telefonaktiebolaget L M Ericsson (publ)
Inventors:
Mats Sagfors, Johan Torsner, Stefan Wager
Abstract: The invention relates to a method of assessing the viability of a thawed cell wherein the cell is a gamete, an embryo, a karyoplast, a putative stem cell population, a stem cell precursor population or a stem cell population. The method includes incubating the thawed cell in a culture medium including a plurality of amino acids and determining the change in concentration in the medium of at least one amino acid.
Abstract: A photocontrol device for controlling a powered device includes a housing assembly defining a cavity and including a base assembly. The base assembly includes an outer base member having a base opening, and an inner base member separately formed from the outer base member and mounted in the base opening. A circuit board is disposed in the cavity. A photosensor is connected to the circuit board. An elongate contact member is mechanically and electrically coupled to the circuit board. The elongate contact member is mounted on and extends through the inner base member. The elongate contact member is adapted to electrically connect the photocontrol device with the powered device.
Abstract: The present invention concerns the application of lipidomics to statin treatment for disorders such as cardiovascular disorders. Hence, the invention provides, among other things, a method of correlating a lipid profile with a positive or negative response to a statin treatment regimen by obtaining a lipid profile of a sample from a mammalian subject following commencement of the treatment regimen; and correlating the lipid profile in the sample with a positive or negative response to the treatment regimen. The invention further provides a method of correlating a lipid profile with a positive or negative response to a statin treatment regimen by obtaining a lipid profile of a sample from a mammalian subject before commencement of the treatment regimen; and correlating the lipid profile in the sample with a positive or negative response to the treatment regimen.
Type:
Grant
Filed:
October 24, 2008
Date of Patent:
March 20, 2012
Assignees:
Children's Hospital & Research Center at Oakland, Duke University, Lipomics Technologies, Inc., Mayo Foundation for Medical Education and Research
Inventors:
Rima F. Kaddurah-Daouk, Michelle M. Wiest, Steven M. Watkins, Rebecca Ann Baillie, Madhumita Patnaik, K. Ranga Rama Krishnan, Richard M. Weinshilboum, Ronald M. Krauss
Abstract: An enclosure assembly for use with a fiber optic cable, the cable having a lengthwise cable axis and including a plurality of optical fibers and a jacket surrounding the optical fibers includes an enclosure housing and a cable control clip. The enclosure housing defines a chamber to receive the cable. The cable control clip is configured to be inserted through the cable to extend radially between the optical fibers and the jacket to limit contact between the optical fibers and one or more other components of the cable, and to limit displacement of the enclosure housing relative to the cable when the cable control clip is disposed in the chamber.
Type:
Grant
Filed:
April 20, 2011
Date of Patent:
March 13, 2012
Assignee:
Tyco Electronics Corporation
Inventors:
Julian Mullaney, Justin Everette Thompson, William Alan Carrico
Abstract: The present invention is directed to novel macrocyclic compounds of formula (I) and their pharmaceutically acceptable salts, hydrates or solvates: wherein R1, R2, R3, R4, R5, R6, n1, m, p Z1, Z2, and Z3 are as describe in the specification. The invention also relates to compounds of formula (I) which are antagonists of the motilin receptor and are useful in the treatment of disorders associated with this receptor and with or with motility dysfunction.
Type:
Grant
Filed:
November 19, 2008
Date of Patent:
March 6, 2012
Assignee:
Tranzyme Pharma Inc.
Inventors:
Eric Marsault, Luc Ouellet, Hamid R. Hoveyda
Abstract: A deicing composition is provided. The composition includes a potassium or sodium salt of a carboxylic acid and a lithium salt of a carboxylic acid or lithium nitrate, wherein the molar ratio of lithium to potassium or lithium to sodium is from 10 percent to 80 percent.
Type:
Grant
Filed:
April 8, 2011
Date of Patent:
March 6, 2012
Assignees:
FMC Corporation, Lithium Division, Clemson University
Inventors:
David B. Stokes, Daniel Person Johnston, Prasada Rao Rangaraju, Vijay C. Mehta, Claudio E. Manissero
Abstract: A submersible vehicle for use in a body of liquid includes a vehicle body, a pair of fins coupled to the vehicle body on opposed sides thereof, and a dihedral angle control system. The dihedral angle control is system operative to vary a fin dihedral angle of each of the fins.
Abstract: A process of preparing an elastic thermally bonded nonwoven web, whereby the process is characterized by the following steps: (i) providing a thermally bonded nonwoven precursor web containing thermoplastic fibers, (ii) subjecting the precursor web of step (i) to a drawing treatment in a machine direction at a drawing rate of from 45 to 70%, and a strain rate within a range of from 1000 to 2400%/min at a temperature between the softening point and the melting point of the fibers for preparing the elastic thermally bonded nonwoven web.
Abstract: Compounds of pyridinium salts and methods of their use in medicine, particularly in the prophylaxis and treatment of inflammatory conditions, infectious conditions, as well as immune disorders are disclosed. The present invention also relates to methods of controlling fungi and/or bacteria.
Type:
Grant
Filed:
June 29, 2010
Date of Patent:
February 28, 2012
Assignee:
Mycosol, Inc.
Inventors:
Richard B. Klein, Jeffrey L. Selph, John J. Partridge, John Reinhard
Abstract: A wildlife guard assembly for use with an electrical insulator body includes first and second guard members and an actuator member. The first and second guard members define a seat to receive the insulator body and are connected to one another to permit relative movement between an open position. The first and second guard members define a sideward opening to laterally receive the insulator body into the seat, and a closed position, wherein the first and second guard members at least partially encircle the insulator body to capture the insulator body in the seat. The actuator member is configured to be inserted between the first and second guard members in the open position and, when forcibly displaced radially to an installed position, to force the first and second guard members to move from the open position to the closed position.
Abstract: Methods of making unsaturated polyester compositions are provided and include reacting: (i) plant and animal oil triglycerides, an alkyl ester of a saturated or unsaturated fatty acid or mixtures thereof; (ii) a difunctional, or polyfunctional glycol or mixtures thereof; (iii) a difunctional or polyfunctional acid, their anhydrides or alkyl esters and mixtures thereof; (iv) a strained cycloolefin; (v) a component(s) that function as a compound capable of initiating polymerization at high temperature and which is stable at room temperature; and (vi) low profile additives, fillers and reinforcements.
Abstract: The invention relates to a rock anchor including an elongate, hydraulically inflatable anchor tube made of a ductile material and defining a closed leading end, a trailing end, and a tube cavity extending between the ends. The rock anchor of the invention includes an end cap on a trailing end of the tube, defining a feed aperture in communication with the tube cavity for pressure feeding a liquid substance into the tube cavity for inflating the tube. The end cap includes pressure indicator means configured for indicating when, as a result of pressure feeding of a liquid substance into the tube cavity, a predetermined installation pressure is reached in the tube cavity. The pressure indicator means typically includes a pressure indicator formation displaceable under pressure in the tube cavity, with such displacement being visible from the outside of the end cap.
Abstract: The invention provides an attenuated enterobacterium comprising an attenuating mutation in the fnr gene, and optionally further comprising a heterologous nucleic acid encoding a foreign antigen. Also provided are pharmaceutical formulations comprising the attenuated enterobacteria of the invention. Further disclosed are methods of inducing an immune response in a subject by administration of an immunogenically effective amount of an attenuated enterobacterium or pharmaceutical formulation of the invention.
Type:
Grant
Filed:
July 9, 2009
Date of Patent:
January 24, 2012
Assignee:
North Carolina State University
Inventors:
Hosni M. Hassan, Ryan C. Fink, Matthew R. Evans
Abstract: Methods of applying cyclopropene amine derivatives and compositions thereof to inhibit ethylene receptors in plants and plant material are disclosed. Methods include applying to the plant an effective ethylene response-inhibiting amount of at least one cyclopropene amine compound or composition thereof. Cyclopropene amine compounds, enantiomers, stereoisomers or salts thereof are also provided.
Abstract: The present invention provides etchant solutions including deionized water and an organic acid having a carboxyl radical and a hydroxyl radical. Methods of forming magnetic memory devices are also disclosed.
Type:
Grant
Filed:
August 28, 2008
Date of Patent:
January 10, 2012
Assignee:
Samsung Electronics Co., Ltd.
Inventors:
Yu-Kyung Kim, Chang-Ki Hong, Sang-Jun Choi, Jeong-Nam Han
Abstract: Embodiments of the present invention include a conductive particle that includes a conductive nickel/gold (Ni/Au) complex metal layer having a phosphorous content of less than about 1.5 weight percent formed on the surface of a polymer resin particle. Methods of forming the same are also included. A conductive particle with a Ni/Au complex metal layer having less than about 1.5 weight percent of phosphorous may have relatively high conductivity while providing relatively good adhesion of the Ni/Au metal layer to the polymer resin particle. Further embodiments of the present invention provide an anisotropic adhesive composition comprising a conductive particle according to an embodiment of the invention.
Type:
Grant
Filed:
August 7, 2006
Date of Patent:
January 3, 2012
Assignee:
Cheil Industries, Inc.
Inventors:
Jung Bae Jun, Jin Gyu Park, Heung Se Lee
Abstract: A method of digitally printing textile substrates includes pretreating a textile substrate with a solution that is configured to limit penetration of aqueous colorant into fibers of the textile substrate, drying the pretreated textile substrate for a predetermined period of time, and digitally printing one or more aqueous colorants onto the dried textile substrate. The pretreatment solution comprises a polyamine with a quaternary ammonium compound attached to the polyamine backbone. The pretreatment solution may be applied onto one or both sides of a textile substrate.
Abstract: A vehicular window assembly includes a vehicular window, an inner film unit and an outer film unit. The vehicular window panel has interior and exterior opposed surfaces. The inner film unit includes an inner adhesive layer and an inner film layer adhered to the interior surface of the vehicular window panel by the inner adhesive layer. The outer film unit includes an outer adhesive layer and an outer film layer adhered to the exterior surface of the vehicular window panel by the outer adhesive layer.
Type:
Grant
Filed:
October 15, 2008
Date of Patent:
January 3, 2012
Assignee:
Clear Defense LLC
Inventors:
Tonya M. Cockman, Patrick Haden Jennings, Donald C. Martin
Abstract: The present invention provides novel conformationally-defined macrocyclic compounds that have been demonstrated to be selective agonists of the ghrelin receptor (growth hormone secretagogue receptor, GHS-R1a and subtypes, isoforms and variants thereof). Such compounds are useful as medicaments for treatment and prevention of a range of medical conditions characterized by disturbed gastrointestinal motility including, but not limited to, post-surgical gastroparesis and post-operative ileus in combination with opioid-induced bowel dysfunction. These agents are effective for multiple disorders at dose levels equivalent to those required to treat a single disorder.
Type:
Grant
Filed:
July 6, 2007
Date of Patent:
January 3, 2012
Assignee:
Tranzyme Pharma Inc.
Inventors:
Graeme L. Fraser, Hamid R. Hoveyda, Mark L. Peterson